Every Sample Counts: Central Lab Services That Keep Single and Multi-Site Trials Moving

How 360biolabs connects protocol-specific kit production, laboratory manuals, LIMS-controlled sample tracking, PBMC isolation and 24/7 monitored biobanking to protect the science behind clinical trial data.

The Sample is Where the Science Becomes Real

Clinical trials are often described through protocols, endpoints and milestones. Yet behind every dataset is something far more tangible: a sample collected from a participant, handled by a clinical site, shipped across distance and time, and entrusted to a laboratory team to generate reliable results.

That is why central laboratory services are not simply an operational convenience. For sponsors conducting early-phase or multi-site clinical trials, they are part of the scientific control system. Every tube, shipment, label, storage condition and handoff has the potential to influence downstream analysis. When the work is harmonised early, the data has a stronger foundation.

At 360biolabs, this belief is captured in a phrase that has shaped our laboratory culture for the past decade: “Every Sample Counts”. It is a practical principle. It guides how we design study-specific workflows, how we support clinical sites, how we track samples through our systems, and how we safeguard sample integrity from collection through testing or onward shipment. As clinical trials become more globally distributed, this principle matters more than ever. 

Harmonisation Starts Before the First Sample is Collected

In multi-site clinical trials, variability often begins before a sample reaches the laboratory. Different sites may have different levels of experience, different local workflows and different logistics constraints. A strong central laboratory partner helps reduce that variability before it becomes a data issue.

At its Melbourne facility, 360biolabs assembles and distributes protocol-specific sample collection kits for single- and multi-site studies. These kits can include commonly requested collection supplies or more specialised items tailored to the unique sampling requirements of the study. The goal is to make the collection process simpler for sites while preserving the precision needed for bioanalytical outcomes.

The same thinking applies to laboratory manuals. A well-built manual is more than a set of instructions. It is a shared operating framework for site teams, investigators, laboratory staff and logistics partners. 360biolabs laboratory manuals provide clear guidance for study-specific sample collection, labelling, handling, storage and shipment, helping samples arrive in the required condition for downstream testing.

For sponsors, this creates two important advantages. First, it supports consistency across geographically dispersed sites. Second, it gives site teams confidence at the point where trial execution becomes hands-on.

Chain-of-Custody is Not Just a Compliance Step 

Once a sample is collected, trust depends on traceability. Sponsors need confidence not only in the assay result, but in the full journey that led to it.

Samples received by 360biolabs are entered into our Laboratory Information Management System (LIMS), supporting a complete chain-of-custody from sample receipt through sample testing and onward shipment to the sponsor’s preferred destination. Our tracking systems record key movements across the sample lifecycle, including initial receipt, movement within the 360biolabs facility, storage, relocation, shipping and destruction.
This level of traceability supports auditability, regulatory confidence and operational decision-making. It also helps sponsors manage complex trial designs where samples may need to be split, stored, tested, transferred or shipped to another selected laboratory.

Behind the system is a dedicated logistics team with knowledge of global shipping regulations and import requirements. Working directly with domestic and international courier partners, the team helps coordinate timely delivery of clinical samples across jurisdictions while maintaining the documentation and visibility required for regulated studies.

In practical terms, chain-of-custody is how a central laboratory protects the story of a sample. It shows where the sample was, how it was handled and how it moved through the study. For a sponsor preparing for regulatory review or internal decision-making, that record is essential.

Protecting Samples When Timing and Matrix Matter 

Some samples demand more than careful tracking. They require rapid processing, technical experience and a deep understanding of the biological matrix.

Peripheral blood mononuclear cells (PBMCs) are a clear example. PBMCs can provide a comprehensive view of the immune system’s response to treatment, making them important for pharmacodynamic, vaccine, immunology and immune-monitoring endpoints. However, the reliability of data generated from PBMC-based assays depends on prompt collection, skilled isolation, handling and storage.

360biolabs supports PBMC isolation using multiple techniques, including traditional density gradient underlay, SepMate™, LeucoSep™ and CPT™ approaches. The team has an extensive SOP library with more than 50 custom methods, enabling study-specific flexibility. Quality is supported through NATA accreditation and participation in internal and external proficiency programs.

As part of Central Laboratory Services, 360biolabs also offers RNA/DNA extraction, complex matrix handling and coordination of global shipping to a sponsor’s preferred laboratory. This integrated capability is valuable for programs where cellular, molecular and bioanalytical endpoints need to work together.

For sponsors, the benefit is not only technical. It is operational continuity. Time-sensitive samples can be processed through experienced teams, stored under controlled conditions, and connected to downstream assay support without creating unnecessary handoffs.

Biobanking With The Same Sense Of Responsibility

Clinical samples often represent irreplaceable moments in a participant’s study journey. Protecting them requires infrastructure, monitoring and disciplined processes.

360biolabs secure storage facilities include 24/7 temperature monitoring and generator backup in the event of power disruption. Samples are stored in monitored biobanking facilities designed to safeguard sample integrity under controlled conditions. Combined with LIMS-based receipt and tracking, this infrastructure supports confidence across both short-term study execution and longer-term sample management.

This matters because central laboratory performance is often judged in moments when there is little room for error: a delayed shipment, a complex collection schedule, a time-sensitive isolation, or a study milestone that depends on accurate, reliable sample analysis. The best systems are designed before those moments occur.

A Central Laboratory Partner for Early-Phase Momentum and Global Continuity

360biolabs brings Central Laboratory Services together with broad bioanalytical capability across PK, PD, immunogenicity, biomarkers, vaccines and infectious diseases, flow cytometry, molecular assays and LC-MS/MS. This integration allows sponsors to connect operational sample management with the scientific expertise needed to generate high-quality clinical data.

For early-phase studies in Australia, that connection is especially powerful. Sponsors can access the Australian Advantage: speed, cost-effectiveness and quality, while working with a laboratory partner built for the realities of clinical trial execution. As programs progress, 360biolabs’ connection to the global BioAgilytix laboratory network supports continuity into larger and later-phase international studies.